✦ LIBER ✦

Social anxiety disorder under scrutiny

✍ Scribed by Jonathan R.T. Davidson

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 76 KB
Volume: 11
Category: Article
ISSN: 1091-4269
DOI: 10.1002/(sici)1520-6394(2000)11:3<93::aid-da2>3.0.co;2-7

No coin nor oath required. For personal study only.

✦ Synopsis

Social anxiety disorder (social phobia) is a chronic disabling condition. As with many psychiatric disorders, the condition is likely to have several causes, including genetic and familial factors, early experiences, and cognitive mechanisms. This review will briefly examine the etiology of social anxiety disorder. 11:93-98, 2000.

The approach required during diagnosis of the condition will also be addressed, in particular, the differentiation between social anxiety disorder and other anxiety disorders with similar presentation. The main focus of this article is to review available treatment options for social anxiety disorder, both psychosocial and pharmacotherapeutic. A number of management strategies have shown promise for the treatment of the condition. The International Consensus Group on Depression and Anxiety recently recommended that a selective serotonin reuptake inhibitor (SSRI) should be considered as first-line pharmacotherapy. To date, however, paroxetine is the only SSRI that is licensed for the treatment of social anxiety disorder. Depression and Anxiety

📜 SIMILAR VOLUMES

Cultural aspects in social anxiety and s

Cultural aspects in social anxiety and social anxiety disorder

✍ Stefan G. Hofmann; M.A. Anu Asnaani; Devon E. Hinton 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

To examine cultural aspects in social anxiety and social anxiety disorder (SAD), we reviewed the literature on the prevalence rates, expressions, and treatments of social anxiety/SAD as they relate to culture, race, and ethnicity. We further reviewed factors that contribute to the differences in soc

Tiagabine for social anxiety disorder

✍ Boadie W. Dunlop; Laszlo Papp; Steven J. Garlow; Paul S. Weiss; Bettina T. Knigh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

## Abstract Tiagabine, a selective gamma‐aminobutyric acid (GABA) reuptake inhibitor was evaluated for the treatment of patients with social anxiety disorder (SAD). Adults with SAD received open‐label tiagabine 4–16 mg per day for 12 weeks. Intent‐to‐treat data are available for 54 patients with im

Why take social anxiety disorder serious

Why take social anxiety disorder seriously?

✍ Jean-Pierre Lépine; Antoine Pélissolo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Social anxiety disorder (social phobia) is a disabling psychiatric condition, characterized by a fear of negative evaluation by others. Epidemiological studies have shown a high prevalence of the condition in the general population; the disorder is more common in women than in men. Social anxiety

Social anxiety disorder in callers to th

Social anxiety disorder in callers to the Anxiety Disorders Association of America

✍ Wei Zhang; Jerilyn Ross; Jonathan R.T. Davidson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Social anxiety disorder in adults who st

Social anxiety disorder in adults who stutter

✍ Elaine Blumgart; Yvonne Tran; Ashley Craig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Social anxiety disorder and depression i

Social anxiety disorder and depression in Saudi Arabia

✍ Medhat M. Bassiony 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views